DMS_name stringclasses 68
values | PDB_file stringclasses 68
values | chain stringclasses 8
values | site stringclasses 695
values | wildtype stringclasses 20
values | mutation stringclasses 20
values | mut_name stringlengths 4 7 | DMS_score float64 -7.77 70 | MinMax_normalized_DMS_score float64 0 1 | Rank_quartile_normalized_DMS_score float64 -2.28 3.78 | closest_interface_atom_distance float64 1.4 103 |
|---|---|---|---|---|---|---|---|---|---|---|
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | A | HA8A | 0.53991 | 0.353 | 0.176 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | A | HB8A | 0.53991 | 0.353 | 0.176 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | C | HA8C | -0.841397 | 0.242 | -0.549 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | C | HB8C | -0.841397 | 0.242 | -0.549 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | D | HA8D | -1.796409 | 0.165 | -1.065 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | D | HB8D | -1.796409 | 0.165 | -1.065 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | E | HA8E | -0.226328 | 0.291 | -0.165 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | E | HB8E | -0.226328 | 0.291 | -0.165 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | F | HA8F | 0.463458 | 0.347 | 0.078 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | F | HB8F | 0.463458 | 0.347 | 0.078 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | G | HA8G | -0.542226 | 0.266 | -0.322 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | G | HB8G | -0.542226 | 0.266 | -0.322 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | L | HA8L | -0.924273 | 0.235 | -0.58 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | L | HB8L | -0.924273 | 0.235 | -0.58 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | M | HA8M | -0.581397 | 0.263 | -0.353 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | M | HB8M | -0.581397 | 0.263 | -0.353 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | N | HA8N | -0.321529 | 0.284 | -0.227 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | N | HB8N | -0.321529 | 0.284 | -0.227 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | P | HA8P | -1.896438 | 0.157 | -1.115 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | P | HB8P | -1.896438 | 0.157 | -1.115 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | Q | HA8Q | -1.035516 | 0.226 | -0.628 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | Q | HB8Q | -1.035516 | 0.226 | -0.628 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | R | HA8R | -1.300125 | 0.205 | -0.769 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | R | HB8R | -1.300125 | 0.205 | -0.769 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | V | HA8V | -0.231065 | 0.291 | -0.165 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | V | HB8V | -0.231065 | 0.291 | -0.165 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | W | HA8W | -0.507396 | 0.269 | -0.321 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | W | HB8W | -0.507396 | 0.269 | -0.321 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 8 | H | Y | HA8Y | -1.057593 | 0.224 | -0.643 | 2.4 |
NGF_2018_tanezumab | tanezumab_4edw | B | 8 | H | Y | HB8Y | -1.057593 | 0.224 | -0.643 | 16 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | A | RA9A | -1.598161 | 0.181 | -0.957 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | A | RB9A | -1.598161 | 0.181 | -0.957 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | C | RA9C | 3.562993 | 0.597 | 1.451 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | C | RB9C | 3.562993 | 0.597 | 1.451 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | D | RA9D | -1.411472 | 0.196 | -0.8 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | D | RB9D | -1.411472 | 0.196 | -0.8 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | E | RA9E | -1.461012 | 0.192 | -0.863 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | E | RB9E | -1.461012 | 0.192 | -0.863 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | F | RA9F | -0.845091 | 0.241 | -0.549 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | F | RB9F | -0.845091 | 0.241 | -0.549 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | G | RA9G | -1.17768 | 0.215 | -0.729 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | G | RB9G | -1.17768 | 0.215 | -0.729 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | H | RA9H | -2.259008 | 0.127 | -1.357 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | H | RB9H | -2.259008 | 0.127 | -1.357 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | I | RA9I | 0.768577 | 0.372 | 0.216 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | I | RB9I | 0.768577 | 0.372 | 0.216 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | K | RA9K | -1.12842 | 0.219 | -0.682 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | K | RB9K | -1.12842 | 0.219 | -0.682 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | L | RA9L | -0.564386 | 0.264 | -0.353 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | L | RB9L | -0.564386 | 0.264 | -0.353 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | M | RA9M | -2.636679 | 0.097 | -1.571 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | M | RB9M | -2.636679 | 0.097 | -1.571 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | N | RA9N | -1.540779 | 0.185 | -0.886 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | N | RB9N | -1.540779 | 0.185 | -0.886 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | P | RA9P | -0.490014 | 0.27 | -0.282 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | P | RB9P | -0.490014 | 0.27 | -0.282 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | Q | RA9Q | -0.865568 | 0.24 | -0.549 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | Q | RB9Q | -0.865568 | 0.24 | -0.549 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | S | RA9S | -1.27639 | 0.207 | -0.769 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | S | RB9S | -1.27639 | 0.207 | -0.769 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | T | RA9T | -2.290004 | 0.125 | -1.408 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | T | RB9T | -2.290004 | 0.125 | -1.408 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | V | RA9V | -1.164816 | 0.216 | -0.724 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | V | RB9V | -1.164816 | 0.216 | -0.724 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | W | RA9W | -0.125063 | 0.3 | -0.071 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | W | RB9W | -0.125063 | 0.3 | -0.071 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 9 | R | Y | RA9Y | 0.287715 | 0.333 | 0.078 | 1.5 |
NGF_2018_tanezumab | tanezumab_4edw | B | 9 | R | Y | RB9Y | 0.287715 | 0.333 | 0.078 | 16.8 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | A | GA10A | -1.698927 | 0.172 | -1.027 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | A | GB10A | -1.698927 | 0.172 | -1.027 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | C | GA10C | 0.317661 | 0.335 | 0.078 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | C | GB10C | 0.317661 | 0.335 | 0.078 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | D | GA10D | -1.124539 | 0.219 | -0.675 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | D | GB10D | -1.124539 | 0.219 | -0.675 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | E | GA10E | -0.820335 | 0.243 | -0.502 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | E | GB10E | -0.820335 | 0.243 | -0.502 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | F | GA10F | 0.755638 | 0.371 | 0.216 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | F | GB10F | 0.755638 | 0.371 | 0.216 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | H | GA10H | -0.618613 | 0.26 | -0.353 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | H | GB10H | -0.618613 | 0.26 | -0.353 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | I | GA10I | 5.129283 | 0.724 | 2.373 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | I | GB10I | 5.129283 | 0.724 | 2.373 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | K | GA10K | 0.799694 | 0.374 | 0.216 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | K | GB10K | 0.799694 | 0.374 | 0.216 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | L | GA10L | 2.562993 | 0.517 | 0.902 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | L | GB10L | 2.562993 | 0.517 | 0.902 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | M | GA10M | -3.829324 | 0 | -1.831 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | M | GB10M | -3.829324 | 0 | -1.831 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | N | GA10N | -0.021969 | 0.308 | -0.005 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | N | GB10N | -0.021969 | 0.308 | -0.005 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | P | GA10P | 0.013876 | 0.311 | 0 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | P | GB10P | 0.013876 | 0.311 | 0 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | Q | GA10Q | -0.954855 | 0.233 | -0.58 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | Q | GB10Q | -0.954855 | 0.233 | -0.58 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | R | GA10R | -1.286242 | 0.206 | -0.769 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | R | GB10R | -1.286242 | 0.206 | -0.769 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | S | GA10S | -0.485916 | 0.27 | -0.282 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | S | GB10S | -0.485916 | 0.27 | -0.282 | 16.3 |
NGF_2018_tanezumab | tanezumab_4edw | A | 10 | G | T | GA10T | -3.021969 | 0.066 | -1.717 | 1.8 |
NGF_2018_tanezumab | tanezumab_4edw | B | 10 | G | T | GB10T | -3.021969 | 0.066 | -1.717 | 16.3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.